SPRY vs TECH
ARS Pharmaceuticals, Inc (SPRY) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
SPRY currently screens at market cap $983.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the SPRY and TECH stock pages for the full models.
Not investment advice.